首页> 外文会议>International Symposium on Tonsils and Mucosal Barriers of Upper Airways >Protection of PneumococcaS Infection by Maternal intranasal Immunization with Pneumococcal Surface Protein A
【24h】

Protection of PneumococcaS Infection by Maternal intranasal Immunization with Pneumococcal Surface Protein A

机译:母体鼻内免疫肺炎球菌表面蛋白A的保护

获取原文

摘要

Streptococcus pneumoniae is one of the important causative pathogens for both upper and lower respiratory tract infections during childhood. The current study was designed to evaluate the protection against fatal pneu-mococcal infections during the infant period by maternal immunization with pneumococcal surface protein A (PspA). Four-week-old females BALB/c mice were immunized with PspAandcholera toxin B(CTB)intranasallytwice a weekfor 3 weeks. After mating, the 10-day-old offspring of these mice were intraperitoneally (i.p.) infected with 5. pneumoniae to evaluate survival. Anti-PspA-specific IgG antibody was induced in the sera of mother and offspring. The survival times to death after systemic fatal pneumococcal infections were significantly extended among offspring delivered from PspA-immunized mothers than the controls. Current findings suggest that maternal intranasal immunization with PspA is an attractive procedure against pneumococcal infections in early childhood.
机译:肺炎链球菌是儿童时期上呼吸道感染的重要致病病原体之一。目前的研究旨在通过母体免疫肺炎球菌表面蛋白A(PSPA)来评估婴幼儿期间对致命性肺癌患者的保护。用Pspaandcholera毒素B(CTB)免疫为期四周的女性Balb / c小鼠3周的每周一次免疫3周。交配后,这些小鼠的10天历史的后代是腹膜内(I.P.)感染5.肺炎评估存活率。在母亲和后代血清中诱导抗PSPA特异性IgG抗体。在从PSPA免疫母亲递送的后代患者比对照组中,在系统性致命的肺炎球菌感染后的生存时间显着延伸。目前的调查结果表明,与PSPA的孕产妇鼻内免疫接种是患儿童早期肺炎球菌感染的有吸引力的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号